Amarin Corp. Plc (AMRN)

2.83
0.04 1.40
NASDAQ : Health Technology
Prev Close 2.87
Open 2.88
Day Low/High 2.80 / 2.90
52 Wk Low/High 2.35 / 4.60
Volume 1.80M
Avg Volume 2.64M
Exchange NASDAQ
Shares Outstanding 293.57M
Market Cap 869.01M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Interesting AMRN Call Options For August 10th

Interesting AMRN Call Options For August 10th

Investors in Amarin Corp plc saw new options begin trading today, for the August 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for the new August 10th contracts and identified the following call contract of particular interest.

First Week Of August 17th Options Trading For Amarin (AMRN)

Investors in Amarin Corp plc saw new options begin trading this week, for the August 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 87 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of December 21st Options Trading For Amarin (AMRN)

Investors in Amarin Corp plc saw new options become available this week, for the December 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance And Updates On REDUCE-IT Cardiovascular Outcomes Study Progress And Vascepa® Promotion Initiatives

Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance And Updates On REDUCE-IT Cardiovascular Outcomes Study Progress And Vascepa® Promotion Initiatives

Over 97% of Final Patient Visits in REDUCE-IT Completed or Scheduled for Near-Term Completion

Amarin Commemorates National Triglycerides Day On March 28

Amarin Commemorates National Triglycerides Day On March 28

Increasing Awareness of Triglycerides and a Call to Action for People to Talk to Their Doctors, Nurses & Pharmacists About Their Triglyceride Levels

Amarin Announces First Middle East Approval For Vascepa®

Amarin Announces First Middle East Approval For Vascepa®

Lebanon Approves Vascepa for Sale, First in Series of Anticipated Approvals

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Bring your A-game in these markets or go home. Just keeping it real. Here is what you need to know on Tuesday.

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.

Twilio, Apache, Tellurian: 'Mad Money' Lightning Round

Twilio, Apache, Tellurian: 'Mad Money' Lightning Round

Jim Cramer spotlights Twilio, Apache, Tellurian, Atara Biotherapeutics, Amarin, Dynavax Technologies

This Bull Still Runs: Cramer's 'Mad Money' Recap (Friday 3/9/18)

This Bull Still Runs: Cramer's 'Mad Money' Recap (Friday 3/9/18)

Jim Cramer says this is a market that triumphs over the gloom by simply taking stock of the good and running with it. He's got your game plan for next week.

Amarin Announces Start Of Final Clinical Site Visits In The REDUCE-IT Cardiovascular Outcomes Study

Amarin Announces Start Of Final Clinical Site Visits In The REDUCE-IT Cardiovascular Outcomes Study

Study Results Anticipated to be Released by End of Q3 2018

Amarin Sponsors Multiple Scientific Presentations Scheduled For 2018 American College Of Cardiology Annual Scientific Session & Expo

Amarin Sponsors Multiple Scientific Presentations Scheduled For 2018 American College Of Cardiology Annual Scientific Session & Expo

Presentations to Include Additional Real-World Data, Clinical and Cost Analyses of Patient Outcomes From Managed Care Databases

First Week of AMRN September 21st Options Trading

First Week of AMRN September 21st Options Trading

Investors in Amarin Corp plc saw new options begin trading this week, for the September 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Amarin's REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark For Reported Primary Events

Amarin's REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark For Reported Primary Events

On Track for Patient Final Study Visits to Commence in March 2018

Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits To Commence In March 2018

Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits To Commence In March 2018

On-Track to Report Clinical Results for this Potential Landmark Study Before the End of Q3 2018